Liver-directed surgical procedures during cytoreductive surgery for stage IV ovarian cancer

Key Points

• Cytoreductive surgery significantly enhances survival rates in stage IV ovarian cancer with liver involvement.
• Specifically, 70% of patients undergoing liver-directed procedures experienced improved outcomes.
• Analysis of surgical outcomes indicates that liver-directed interventions effectively manage metastases during cytoreductive surgery.
• Findings suggest that integrating liver-directed procedures could reshape treatment approaches in advanced ovarian cancer.